Platelet-rich plasma in the treatment of alopecia areata after COVID-19 vaccination

Key Clinical MessageAlopecia areata may develop in patients after COVID-19 vaccination. Platelet-rich plasma (PRP) has an outstanding anti-inflammatory effect and could be an alternative treatment for alopecia patients who are refractory or intolerant to corticosteroids. A 34-year-old female with no systemic illness presented with non-scarring hair loss after the second COVID-19 vaccination shot 4 weeks ago. The hair loss worsened and progressed to severe alopecia areata. We started double-spin PRP therapy. Her hair recovered completely after six courses of PRP treatment.

Automated summary

Alopecia areata can develop after COVID-19 vaccination, and platelet-rich plasma (PRP) can be used as an alternative treatment for refractory or intolerant patients. A 34-year-old female experienced non-scarring hair loss after the second COVID-19 vaccination, which progressed to severe alopecia areata. Complete recovery was achieved after six courses of PRP treatment.